Skip to main content
. 2015 Aug 18;10(8):e0135865. doi: 10.1371/journal.pone.0135865

Table 1. Genotype and allele frequencies of the selected SNPs in CDH1 and CTNNB1 and their associations with risk of breast cancer.

SNPs Genotype Cases (%) Controls (%) P a P b P trend OR (95% CI) P aOR (95% CI) c P c
rs7200690 CDH1 CC 744 (64.14) 852 (63.77) 0.0240 0.4103 Reference Reference
CT 335 (28.88) 422 (31.59) 0.91 (0.76–1.08) 0.2826 0.91 (0.76–1.08) 0.2736
TT 81 (6.98) 62 (4.64) 1.50 (1.06–2.11) 0.0221 1.50 (1.06–2.12) 0.0208
T allele frequency 497 (21.42) 546 (20.43) 0.3916
CT/TT vs. CC (dominant model) 0.98 (0.84–1.16) 0.8496 0.98 (0.84–1.16) 0.8425
TT vs. CT/CC (recessive model) 1.54 (1.10–2.17) 0.0126 1.55 (1.10–2.18) 0.0116
rs12185157 CDH1 AA 337 (29.05) 387 (28.97) 0.6334 0.6277 Reference Reference
AG 540 (46.55) 643 (48.13) 0.91 (0.75–1.11) 0.3395 0.90 (0.74–1.10) 0.3125
GG 283 (24.40) 306 (22.90) 0.94 (0.76–1.17) 0.5873 0.94 (0.75–1.16) 0.5511
G allele frequency 1106 (47.67) 1255 (46.97) 0.6193
AG/GG vs. AA (dominant model) 0.92 (0.77–1.11) 0.3806 0.92 (0.76–1.10) 0.3489
GG vs. AG/AA (recessive model) 1.004 (0.84–1.19) 0.9629 0.996 (0.84–1.19) 0.9659
rs7198799 CDH1 CC 855 (73.71) 981 (73.43) 0.0296 0.4867 Reference Reference
CT 258 (22.24) 423 (24.25) 0.91 (0.76–1.10) 0.3451 0.91 (0.75–1.10) 0.3237
TT 47 (4.05) 31 (2.32) 1.74 (1.095–2.76) 0.0190 1.75 (1.099–2.77) 0.0183
T allele frequency 352 (15.17) 396 (14.45) 0.4709
CT/TT vs. CC (dominant model) 0.99 (0.83–1.18) 0.8749 0.98 (0.82–1.18) 0.8477
TT vs. CT/CC (recessive model) 1.78 (1.12–2.82) 0.0143 1.79 (1.13–2.83) 0.0136
rs17715799 CDH1 AA 781 (67.33) 872 (65.27) 0.0113 0.9953 Reference Reference
AT 302 (26.03) 403 (30.16) 0.84 (0.70–1.10) 0.0592 0.83 (0.70–1.10) 0.0549
TT 77 (6.64) 61 (4.57) 1.41 (0.99–2.00) 0.0544 1.42 (0.998–2.001) 0.0513
T allele frequency 456 (19.66) 525 (19.65) 0.9951
AT/TT vs. AA (dominant model) 0.91 (0.77–1.08) 0.2789 0.91 (0.77–1.08) 0.2677
TT vs. AT/AA (recessive model) 1.49 (1.05–2.10) 0.0245 1.50 (1.06–2.11) 0.0227
rs10431923 CDH1 TT 383 (38.02) 438 (32.78) 0.8221 0.8292 Reference Reference
GT 544 (46.90) 641 (47.98) 0.94 (0.76–1.16) 0.5392 0.93 (0.75–1.15) 0.4851
GG 233 (20.09) 257 (19.24) 0.96 (0.77–1.21) 0.7516 0.96 (0.77–1.20) 0.7075
G allele frequency 1010 (43.53) 1155 (43.23) 0.8264
GT/GG vs. TT (dominant model) 0.95 (0.78–1.16) 0.5937 0.94 (0.77–1.15) 0.5395
GG vs. GT/TT (recessive model) 1.01 (0.86–1.20) 0.9017 1.01 (0.85–1.20) 0.9053
rs7186053 CDH1 GG 602 (51.90) 667 (49.93) 0.0579 0.9724 Reference Reference
AG 429 (36.98) 548 (41.02) 0.88 (0.73–1.03) 0.0962 0.86 (0.73–1.02) 0.0842
AA 129 (11.12) 121 (9.06) 1.18 (0.90–1.55) 0.2291 1.19 (0.91–1.56) 0.2082
A allele frequency 687 (29.61) 790 (29.57) 0.9715
AG/AA vs. GG (dominant model) 0.92 (0.79–1.08) 0.3259 0.92 (0.79–1.10) 0.3102
AA vs. AG/GG (recessive model) 1.26 (0.97–1.63) 0.0872 1.27 (0.98–1.65) 0.0742
rs6499199 CDH1 CC 888 (76.55) 1028 (76.95) 0.2594 0.4872 Reference Reference
CT 241 (20.78) 285 (21.33) 0.98 (0.81–1.19) 0.8295 0.99 (0.82–1.20) 0.9230
TT 31 (2.67) 23 (1.72) 1.56 (0.90–2.70) 0.1110 1.58 (0.91–2.73) 0.1030
T allele frequency 303 (13.06) 331 (12.39) 0.4766
CT/TT vs. CC (dominant model) 1.02 (0.85–1.23) 0.8195 1.03 (0.86–1.25) 0.7230
TT vs. CT/CC (recessive model) 1.57 (0.91–2.70) 0.1063 1.58 (1.001–1.49) 0.1004
rs4783689 CDH1 CC 576 (49.66) 646 (48.35) 0.8095 0.5694 Reference Reference
CT 465 (40.09) 550 (41.17) 0.95 (0.80–1.12) 0.5323 0.95 (0.80–1.12) 0.5069
TT 119 (10.26) 140 (10.48) 0.95 (0.73–1.25) 0.7274 0.95 (0.72–1.24) 0.6913
T allele frequency 703 (30.30) 830 (31.06) 0.5609
CT/TT vs. CC (dominant model) 0.95 (0.81–1.11) 0.5164 0.95 (0.81–1.11) 0.4846
TT vs. CT/CC (recessive model) 0.98 (0.75–1.26) 0.8572 0.97 (0.75–1.26) 0.8263
rs13689 CDH1 TT 766 (66.03) 875 (65.49) 0.0047 0.4013 Reference Reference
CT 330 (28.45) 420 (31.44) 0.90 (0.75–1.07) 0.2226 0.90 (0.76–1.08) 0.2586
CC 64 (5.52) 41 (3.07) 1.78 (1.19–2.67) 0.0050 1.83 (1.22–2.75) 0.0033
C allele frequency 458 (19.74) 502 (18.79) 0.3937
CT/CC vs. TT (dominant model) 0.98 (0.83–1.15) 0.7766 0.98 (0.83–1.16) 0.8013
CC vs. CT/TT (recessive model) 1.84 (1.24–2.75) 0.0027 1.89 (1.27–2.83) 0.0018
rs4533622 CTNNB1 CC 725 (62.50) 817 (61.15) 0.6557 0.6748 Reference Reference
AC 366 (31.55) 444 (33.23) 0.93 (0.78–1.10) 0.3979 0.93 (0.78–1.10) 0.3890
AA 69 (5.95) 75 (5.61) 1.04 (0.74–1.46) 0.8357 1.05 (0.74–1.47) 0.7940
A allele frequency 504 (21.72) 594 (22.23) 0.6666
AC/AA vs. CC (dominant model) 0.95 (0.80–1.11) 0.4899 0.95 (0.80–1.11) 0.4922
AA vs. AC/CC (recessive model) 1.60 (0.76–1.49) 0.7203 1.07 (0.79–1.51) 0.6781
rs4135385 CTNNB1 GG 295 (25.43) 356 (26.65) 0.7748 0.6438 Reference Reference
AG 601 (51.81) 677 (50.67) 1.07 (0.89–1.30) 0.4765 1.08 (0.89–1.31) 0.4318
AA 264 (22.76) 303 (22.68) 1.05 (0.84–1.32) 0.6639 1.06 (0.85–1.33) 0.5947
A allele frequency 1129 (48.66) 1283 (48.02) 0.6480
AG/AA vs. GG (dominant model) 1.07 (0.89–1.27) 0.4908 1.07 (0.90–1.29) 0.4350
AA vs. AG/GG (recessive model) 1.01 (0.83–1.21) 0.9625 1.01 (0.84–1.22) 0.9098
rs2293303 CTNNB1 CC 879 (75.78) 1048 (78.44) 0.0629 0.0444 Reference Reference
TC 251 (21.64) 269 (20.13) 1.11 (0.92–1.35) 0.2814 1.11 (0.91–1.35) 0.2961
TT 30 (2.59) 19 (1.42) 1.88 (1.05–3.37) 0.0330 1.92 (1.07–3.43) 0.0288
T allele frequency 311 (13.41) 307 (11.49) 0.0404
TC/TT vs. CC (dominant model) 1.16 (0.97–1.40) 0.1133 1.16 (0.97–1.40) 0.1113
TT vs. TC/CC (recessive model) 1.94 (1.08–3.51) 0.0272 1.97 (1.09–3.55) 0.0246

a Two-sided χ2 test for difference in frequency distribution of genotypes between cases and controls.

b Two-sided χ2 test for difference in frequency distribution of alleles between cases and controls.

c Adjusted for age at menarche, age of first birth and family history of cancer in first-degree relatives.

Bold numbers indicate a statistical significance at 0.05 level.